14-Nov-2014 - Eurofins Genomics B.V.

Eurofins Genomics Achieves GLP Certification

Eurofins Genomics has now achieved Good Laboratory Practice (GLP) certification for DNA sequencing services, the first genomic service provider in Germany to attain such qualification.

Good Laboratory Practice is a required standard for laboratories conducting non-clinical safety studies, for example, toxicology and pharmacology studies in animals. It is also required for non-clinical safety studies for the development of drugs, small molecules, vaccines and gene therapeutics. GLP standards are also critical for the development of diagnostic kits and device validation (FDA and patent submissions), the analyses of production strains and GMO plants like genetic stability testing (e.g. analysis of inserted DNA and its transcripts, etc.). Eurofins Genomics is GLP certified for "DNA sequencing for genotyping and safety testing of GMOs, microorganisms, viruses, cell banks and cell lines". With this certificate, Eurofins Genomics offers not only Sanger sequencing services under GLP, but also next generation sequencing (NGS) applications.

Facts, background information, dossiers
  • Eurofins
  • GLP
  • DNA sequencing
More about Eurofins
  • News

    Eurofins scientific acquires two North American companies

    By acquiring EnvironeX Group Inc. in Canada and TestAmerica in the USA Eurofins expands its testing capabilities in the North American market. EnvironeX Group Inc. - bioanalytical testing in Canada Founded in 2005 by Marc Hamilton and supported by PCP since 2015, EnvironeX is a leading prov ... more

    Eurofins closes acquisition of cosmetic testing lab in France

    Eurofins Scientific announces that it has successfully closed the acquisition of Laboratoire Dermscan SAS (“Dermscan”), a leading provider of Cosmetic & Personal Care Products Testing services in Europe. Dermscan was founded in 1990 in Lyon as a family-owned business. After nearly three dec ... more

    Eurofins acquires German pharma quality service company

    Eurofins Scientific announces that it has signed an exclusive agreement to acquire PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH (“PHAST”), one of Europe’s leading service providers in the field of pharmaceutical products quality. The transaction is expected to close in the ... more